The magnitude of QT prolongation may perhaps increase with increasing concentrations of XENLETA or expanding the speed of infusion on the intravenous formulation. Thus, the recommended dose and infusion charge should not be exceeded. Modifications in serum uric acid concentrations from baseline in stages G1–G3b are summarized in Tables ​Tables33 https://pearlm419cgk1.wikistatement.com/user